Greg Renza

Stock Analyst at RBC Capital

(2.78)
# 1,742
Out of 4,944 analysts
1
Total ratings
100%
Success rate
29.23%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Greg Renza

BeOne Medicines
Apr 7, 2025
Initiates: Outperform
Price Target: $312
Current: $307.51
Upside: +1.46%